Chase Coleman’s Health Catalyst HCAT Stock Holding History

Chase Coleman’s Portfolio HCAT Stock Details HCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-50,000	Closed	-$1.98M	–	122
2021 Q4	$1.98M	Hold	50,000	–	–	﹤0.01%	151
2021 Q3	$2.5M	Hold	50,000	–	–	﹤0.01%	144
2021 Q2	$2.78M	Hold	50,000	–	–	0.01%	131
2021 Q1	$2.34M	Hold	50,000	–	–	0.01%	113
2020 Q4	$2.18M	Hold	50,000	–	–	0.01%	91
2020 Q3	$1.83M	Hold	50,000	–	–	0.01%	84
2020 Q2	$1.46M	Hold	50,000	–	–	0.01%	68
2020 Q1	$1.31M	Hold	50,000	–	–	0.01%	69
2019 Q4	$1.74M	Hold	50,000	–	–	0.01%	68
2019 Q3	$1.58M	Buy	+50,000	New	+$1.97M	0.01%	75

Other funds holding HCAT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Chase Coleman's HCAT Position: Q1 2022 in Review

Chase Coleman sold out of Health Catalyst (HCAT) in Q1 2022, closing a stake of 50,000 shares — an estimated $1.98M sold.

Chase Coleman first reported a position in HCAT in Q3 2019 and held it in 10 quarters. The position peaked at $2.78M in Q2 2021. 185 funds tracked by Wall St. Rank hold HCAT as of Q1 2022.

Chase Coleman reported no remaining Health Catalyst position as of Q1 2022 after selling out during the quarter.
Chase Coleman sold 50,000 Health Catalyst shares in Q1 2022, an estimated $1.98M.
Chase Coleman first reported a position in Health Catalyst in Q3 2019 and held it in 10 quarters.
Chase Coleman's Health Catalyst position peaked at $2.78M in Q2 2021.
185 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2022.

Based on Tiger Global Management's 13F filing for Q1 2022, filed 16 May 2022.